Montreal Canadiens’ Centre player, Max Domi will be walking at the Sun Life Walk to Cure Diabetes for JDRF in Montreal at the Centre de la nature de Laval on Sunday June 9, 2019.
JDRF Expresses Profound Loss at the Passing of Helaine Shiff, co-founder of JDRF Canada
JDRF Canada is deeply saddened at the loss of one of its founders, Helaine Shiff. “Helaine was a remarkable woman and her legacy…
Boston Pizza is advancing the academic goals of young people through two new initiatives in support of JDRF
Boston Pizza Foundation Future Prospects is committed to helping youth be the best they can be and has partnered with JDRF to improve the lives of those living with type 1 diabetes (T1D) – an autoimmune disease that affects 300,000 Canadians.
JDRF International Board Appoints Leading Diabetes Researcher and Advocate Aaron J. Kowalski, Ph.D. as New President & CEO
Internationally recognized diabetes expert, first JDRF CEO with T1D will lead next phase of focused effort to end type 1 diabetes
Sun Life deepens commitment to fight type 1 diabetes in Canada with title sponsorship of JDRF signature fundraising event, the Sun Life Ride to Defeat Diabetes for JDRF
Sponsorship enables increased awareness of type 1 diabetes and investment in research, building upon Sun Life’s global commitment toward type 1 and type 2 diabetes
JDRF Canada is extremely pleased with the House of Commons Standing Committee on Health Report on a Diabetes Strategy for Canada
OTTAWA, ON – (April 10, 2019) — JDRF is very pleased with the 11 recommendations made today by the House of Commons Standing Committee on Health in their report: A Diabetes Strategy for Canada, in alignment with the organization’s recommendations included in their 2019 pre-budget submission.
JDRF announces new Chief Scientific Officer, Dr. Sarah Linklater
JDRF Canada is pleased to announce the appointment of Dr. Sarah Linklater as Chief Scientific Officer (CSO). Sarah has over a decade of extensive experience as a professional scientific editor, with a focus on clinical diabetes and endocrinology, basic immunology and other areas of the life sciences.
JDRF welcomes Government’s decision to end RDSP clawbacks when DTC status lost, but says opportunity missed to support Canadians with diabetes through a national diabetes strategy
JDRF Canada, the leading global funder of type 1 diabetes research, welcomed the news in this year’s federal budget that the government intends to end the practice of clawing back contributions to Registered Disability Savings Plans (RDSPs) for those whose eligibility status for the Disability Tax Credit (DTC) has changed.
Lilly Canada and JDRF Canada Award Post-doctoral Fellowships in Type 1 Diabetes Research
Two pioneering Canadian investigators pursuing careers in type 1 diabetes research have each been awarded a post-doctoral fellowship ($60,000 CAD), thanks to a longstanding partnership between Eli Lilly Canada Inc. (Lilly Canada) and JDRF Canada.
JDRF Canada and Diabetes Canada light the province of BC blue on World Diabetes Day Nov. 14th to raise awareness
JDRF Canada and Diabetes Canada light the province of BC blue on World Diabetes Day Nov. 14th to raise awareness
JDRF’s promise to the T1D Community
November is National Diabetes Awareness Month and JDRF is kicking it off by making a bold public promise.
JDRF celebrates Health Canada’s new licence for technology that will improve the lives of people with type 1 diabetes
Approval of Canada’s first Hybrid Closed-Loop System will help Canadians with type 1 diabetes keep their blood sugar levels in an optimal range for a greater amount of time